Back
Curis 10K Form
Buy
68
CRIS
Curis
Last Price:
16.70
Seasonality Move:
-3.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | CRIS/Curis Quarterly |
2023-08-03 | 10Q | CRIS/Curis Quarterly |
2023-05-04 | 10Q | CRIS/Curis Quarterly |
2022-11-09 | 10Q | CRIS/Curis Quarterly |
2022-08-04 | 10Q | CRIS/Curis Quarterly |
2022-05-05 | 10Q | CRIS/Curis Quarterly |
Receive CRIS News And Ratings
See the #1 stock for the next 7 days that we like better than CRIS
CRIS Financial Statistics
Sales & Book Value
Annual Sales: | $10.02M |
---|---|
Cash Flow: | $-10.19M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.34 |
Price / Book: | 4.9 |
Profitability
EPS (TTM): | -8.96000 |
---|---|
Net Income (TTM): | $-47.41M |
Gross Margin: | $9.81M |
Return on Equity: | -149.45% |
Return on Assets: | -52.11% |
Curis Earnings Forecast
Key Curis Financial Ratios
- The Gross Profit Margin over the past 24 years for CRIS is 97.88%.
- The Selling, General & Administrative Expenses for CRIS have been equal to 186.04% of Gross Profit Margin.
- The Research & Development expenses have been 394.05% of Revenue.
- The Interest Expense is -4.26% of Operating Income.
- The Net Earning history of CRIS is -473.04% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 16 years.
Curis Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CRIS |
CUSIP: | 231269 |
Website: | curis.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.51 |
Quick Ratio: | 4.37 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |